HSIC
60
-2
CI
63
7
CMCSA
48
-2
GWW
76
2
DUK
64
7
DNB
82
-2
PPG
61
-4
HPQ
66
6
TAP
63
2
MLM
58
-2
C
62
-3
PSA
63
2
DHR
41
2
VRSK
82
2
BF.B
33
-4
FDX
44
-2
VMC
60
-2
GE
72
4
SLG
64
-2
CF
56
3
HSIC
60
-2
CI
63
7
CMCSA
48
-2
GWW
76
2
DUK
64
7
DNB
82
-2
PPG
61
-4
HPQ
66
6
TAP
63
2
MLM
58
-2
C
62
-3
PSA
63
2
DHR
41
2
VRSK
82
2
BF.B
33
-4
FDX
44
-2
VMC
60
-2
GE
72
4
SLG
64
-2
CF
56
3
Financhill
Back

Adaptimmune Therapeutics PLC Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.71
Seasonality Move:
53.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Adaptimmune Therapeutics PLC Stock Forecast

  • Is Adaptimmune Therapeutics PLC Stock Undervalued?
    The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.68. The Score for ADAP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Adaptimmune Therapeutics PLC Stock Go Up Next Year?

Data Unavailable

Adaptimmune Therapeutics PLC Stock Rating

Data Unavailable

Adaptimmune Therapeutics PLC Stock Price History

Is ADAP stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
adaptimmune.com

52-Week Data

52-Week High:
2.05
52-Week Low:
0.42

Prediction Charts

Market Cap:
174M
Price in USD:
0.68
Volume:
383.2K
Beta:
2.15

Technical Analysis

SMA50:
0.82
SMA100:
1.00
SMA200:
1.11
52-Wk Change:
46.24%

Stock Predictions

  • Is Adaptimmune Therapeutics PLC stock public?
    Yes, Adaptimmune Therapeutics PLC is a publicly traded company.
  • What is the Adaptimmune Therapeutics PLC stock quote today?
    The Adaptimmune Therapeutics PLC stock price is 0.68 USD today.
  • How to buy Adaptimmune Therapeutics PLC stock online?
    You can buy Adaptimmune Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-7 0.82 0.78 0.83 0.77
Nov-8 0.78 0.80 0.80 0.75
Nov-11 0.81 0.82 0.83 0.78
Nov-12 0.82 0.79 0.82 0.76
Nov-13 0.82 0.77 0.83 0.75
Nov-14 0.81 0.59 0.81 0.58
Nov-15 0.59 0.59 0.61 0.58
Nov-18 0.60 0.60 0.64 0.58
Nov-19 0.60 0.67 0.68 0.57
Nov-20 0.68 0.66 0.71 0.64
Nov-21 0.66 0.64 0.68 0.63
Nov-22 0.63 0.66 0.66 0.60
Nov-25 0.68 0.70 0.71 0.66
Nov-26 0.71 0.68 0.71 0.68

Adaptimmune Therapeutics PLC Earnings

Data Unavailable

Adaptimmune Therapeutics PLC Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.